GSK Plus Sanofi: The COVID-19 Vaccine Dream Team?

Tried-And-Tested Platforms Could Pay Off

 
• By Andrew McConaghie
  
GSK_HQ
By pooling its expertise and manufacturing scale with rivals Sanofi on the COVID-19 vaccine, GSK is increasing the odds of success
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip